Paul V. Fish

4.7k total citations · 1 hit paper
59 papers, 3.0k citations indexed

About

Paul V. Fish is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Paul V. Fish has authored 59 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 19 papers in Organic Chemistry and 11 papers in Pharmacology. Recurrent topics in Paul V. Fish's work include Cholinesterase and Neurodegenerative Diseases (10 papers), Chemical synthesis and alkaloids (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Paul V. Fish is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (10 papers), Chemical synthesis and alkaloids (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Paul V. Fish collaborates with scholars based in United Kingdom, United States and Canada. Paul V. Fish's co-authors include Matthieu Schapira, C. Bountra, C.H. Arrowsmith, Kevin Lee, Li Di, Takashi Mano, William S. Johnson, Elliott D. Bayle, David Steadman and Paul J. Whiting and has published in prestigious journals such as Nature Reviews Drug Discovery, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Paul V. Fish

58 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic protein families: a new frontier for drug discovery

2012 1.0k citations Paul V. Fish, Matthieu Schapira et al. profile →

Peers

Countries citing papers authored by Paul V. Fish

Since Specialization

Citations

This map shows the geographic impact of Paul V. Fish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul V. Fish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul V. Fish more than expected).

Fields of papers citing papers by Paul V. Fish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul V. Fish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul V. Fish. The network helps show where Paul V. Fish may publish in the future.

Co-authorship network of co-authors of Paul V. Fish

This figure shows the co-authorship network connecting the top 25 collaborators of Paul V. Fish. A scholar is included among the top collaborators of Paul V. Fish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul V. Fish. Paul V. Fish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Large-scale synthesis of Notum inhibitor 1-(2,4-dichloro-3-(trifluoromethyl)-phenyl)-1 H -1,2,3-triazole (ARUK3001185) employing a modified Sakai reaction as the key step 2022 ·RSC Advances ·Benjamin N. Atkinson, Nicky J. Willis, (unknown), (unknown), (unknown), (unknown), (unknown), Paul V. Fish	2
2	Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors 2021 ·SLAS DISCOVERY ·Kanchan Devkota, Matthieu Schapira, Sumera Perveen, Aliakbar Khalili Yazdi, Fengling Li, Irene Chau, Pegah Ghiabi, Taraneh Hajian, P. Loppnau, Albina Bolotokova, K.J.F. Satchell, Ke Wang, Deyao Li, Jing Liu, David Smil, Minkui Luo, Jian Jin, Paul V. Fish, Peter J. Brown, Masoud Vedadi	55
3	Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding 2020 ·SLAS DISCOVERY ·(unknown), Magda Bictash, Paul V. Fish, Lewis D. Griffin, Fredrik Svensson	36
4	New approaches for the treatment of Alzheimer’s disease 2018 ·Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, David Steadman, Elliott D. Bayle, Paul J. Whiting	134
5	Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT_2C Receptor Agonists 2015 ·ACS Medicinal Chemistry Letters ·Guy Rouquet, Dianna E. Moore, Malcolm Spain, Daniel M. Allwood, Claudio Battilocchio, David C. Blakemore, Paul V. Fish, Stephen Jenkinson, Alan S. Jessiman, Steven V. Ley, Gordon McMurray, Richard Storer	11
6	The role of miR-29b/collagen Type I/BMP-1 pathway in angiogenesis in the ischaemic human heart 2012 ·Cardiovascular Research ·(unknown), Dominic Sweeney, G. Thomas, Paul V. Fish, D P Taggart, Suzanne M. Watt, Enca Martin‐Rendon	1
7	Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: Improving metabolic stability and reducing ion channel activity 2010 ·Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, Paul V. Fish, (unknown), Gerwyn Bish, (unknown), (unknown), Anthony Harrison, Jean-Loïc Le Net, Stephen C. Phillips, (unknown), (unknown), Alan Stobie, Florian Wakenhut, (unknown), (unknown), Gavin A. Whitlock	3
8	N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: Impact of small structural modifications on P-gp recognition and CNS penetration 2009 ·Bioorganic & Medicinal Chemistry Letters ·Florian Wakenhut, (unknown), Paul V. Fish, M. Jonathan Fray, Anthony Harrison, (unknown), Stephen C. Phillips, Alan Stobie, (unknown), (unknown), Gavin A. Whitlock	7
9	6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective α1A adrenoceptor partial agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Lee R. Roberts, Paul V. Fish, Richard Storer, Gavin A. Whitlock	13
10	4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: Design, synthesis and structure–activity relationships 2009 ·Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, Mark D. Andrews, M. Jonathan Fray, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	13
11	Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template 2009 ·Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, Florian Wakenhut, Thomas Ryckmans, Alan Stobie	3
12	Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity 2008 ·Bioorganic & Medicinal Chemistry Letters ·Gavin A. Whitlock, Paul V. Fish, M. Jonathan Fray, Alan Stobie, Florian Wakenhut	22
13	Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition 2008 ·Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, (unknown), (unknown), (unknown), (unknown), (unknown), Kimberly S. Para, (unknown), Thomas Ryckmans, Cory M. Stiff, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	26
14	Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity 2008 ·Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, Nancy S. Barta, David Gray, Thomas Ryckmans, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	11
15	Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: Design, synthesis, and evaluation as topically applied, dermal anti-scarring agents 2008 ·Bioorganic & Medicinal Chemistry Letters ·Simon Bailey, Paul V. Fish, (unknown), Jon Bordner, Doris Greiling, Kim James, Andrew B. McElroy, James E. Mills, (unknown), Robert O. Webster	19
16	[4-(Phenoxy)pyridin-3-yl]methylamines: A new class of selective noradrenaline reuptake inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, Thomas Ryckmans, Alan Stobie, Florian Wakenhut	9
17	N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Florian Wakenhut, Paul V. Fish, M. Jonathan Fray, Ian Gurrell, James E. Mills, Alan Stobie, Gavin A. Whitlock	10
18	N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, M. Jonathan Fray, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	13
19	Structure–activity relationships of N-substituted piperazine amine reuptake inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, Gerwyn Bish, Paul V. Fish, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	18
20	N-(1,2-Diphenylethyl)piperazines: A new class of dual serotonin/noradrenaline reuptake inhibitor 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, Gerwyn Bish, Alan D. Brown, Paul V. Fish, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact